Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Joshua Field, MD, MS
Healthcare Provider Associate Medical Director
Blood Center of Wisconsin
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, Wisconsin, United States
Dr. Joshua Field is an Associate Medical Director at the Blood Center of Wisconsin and an Associate Professor of Medicine in the Division of Hematology and Oncology at the Medical College of Wisconsin. Dr. Field specializes in the treatment of sickle cell disease and other benign hematological disorders at Froedtert Hospital. Dr. Field graduated medical school from the University of Iowa. He completed an internal medicine residency and fellowships in hematology and transfusion medicine at Washington University in St. Louis, where he was chief resident in internal medicine and chief fellow in hematology and oncology. Dr. Field is board certified in transfusion medicine and hematology. He conducts clinical and translational research studies in adults with sickle cell disease.
Representative Publications:
Environmental tobacco smoke and airway obstruction in children with sickle cell anemia
Sickle solubility test to screen for sickle cell trait: what’s the harm?
Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease
Related Content
-
St. Louis Children’s HospitalThe St. Louis Children's Hospital Sickle...
-
Pierrette (P) Mimi Poinsett, MDDr. Pierrette Mimi Poinsett is a physici...
-
Cindy Neunert, MDCindy Neunert, MD is a practicing pediat...
-
Sickle Cell Disease: Reducing the Global Disease BurdenSickle cell disease has been largely an ...
-
A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)Limited evidence guides opioid dosing st...
-
Webinar Series: Sickle Cell Science: Path to Progress – Bone Marrow Transplants, Other Therapies, and Sickle C...To commemorate Sickle Cell Awareness Mon...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...